Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Fast non-enhanced abdominal examination protocols in PET/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET/CT.

Seith F, Schraml C, Reischl G, Nikolaou K, Pfannenberg C, la Fougère C, Schwenzer N.

Radiol Med. 2018 Jun 30. doi: 10.1007/s11547-018-0917-0. [Epub ahead of print]

PMID:
29961229
2.

Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis.

Lauer UM, Schell M, Beil J, Berchtold S, Koppenhöfer U, Glatzle J, Königsrainer A, Möhle R, Nann D, Fend F, Pfannenberg C, Bitzer M, Malek NP.

Clin Cancer Res. 2018 Sep 15;24(18):4388-4398. doi: 10.1158/1078-0432.CCR-18-0244. Epub 2018 May 17.

PMID:
29773661
3.

Simultaneous multislice diffusion-weighted imaging in whole-body positron emission tomography/magnetic resonance imaging for multiparametric examination in oncological patients.

Taron J, Schraml C, Pfannenberg C, Reimold M, Schwenzer N, Nikolaou K, Martirosian P, Seith F.

Eur Radiol. 2018 Aug;28(8):3372-3383. doi: 10.1007/s00330-017-5216-y. Epub 2018 Feb 26.

PMID:
29484459
4.

Imaging giant cell arteritis and Aortitis in contrast enhanced 18F-FDG PET/CT: Which imaging score correlates best with laboratory inflammation markers?

Olthof SC, Krumm P, Henes J, Nikolaou K, la Fougère C, Pfannenberg C, Schwenzer N.

Eur J Radiol. 2018 Feb;99:94-102. doi: 10.1016/j.ejrad.2017.12.021. Epub 2017 Dec 27.

PMID:
29362158
5.

Correlation of Brown Adipose Tissue with Other Body Fat Compartments and Patient Characteristics: A Retrospective Analysis in a Large Patient Cohort Using PET/CT.

Brendle C, Werner MK, Schmadl M, la Fougère C, Nikolaou K, Stefan N, Pfannenberg C.

Acad Radiol. 2018 Jan;25(1):102-110. doi: 10.1016/j.acra.2017.09.007. Epub 2017 Nov 3.

PMID:
29108812
6.

Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.

Boeke S, Thorwarth D, Mönnich D, Pfannenberg C, Reischl G, La Fougère C, Nikolaou K, Mauz PS, Paulsen F, Zips D, Welz S.

Acta Oncol. 2017 Nov;56(11):1571-1576. doi: 10.1080/0284186X.2017.1372626. Epub 2017 Sep 11.

PMID:
28891398
7.

Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer.

Mönnich D, Thorwarth D, Leibfarth S, Pfannenberg C, Reischl G, Mauz PS, Nikolaou K, la Fougère C, Zips D, Welz S.

Acta Oncol. 2017 Nov;56(11):1577-1582. doi: 10.1080/0284186X.2017.1363910. Epub 2017 Aug 29.

PMID:
28849721
8.

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start.

Seith F, Forschner A, Schmidt H, Pfannenberg C, Gückel B, Nikolaou K, la Fougère C, Garbe C, Schwenzer N.

Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):95-101. doi: 10.1007/s00259-017-3813-2. Epub 2017 Aug 22.

PMID:
28831583
9.

Pancreatic Ductal Adenocarcinoma With High Radiotracer Uptake in 68Ga-Prostate-Specific Membrane Antigen PET/CT.

Sahbai S, Rieping P, Pfannenberg C, la Fougére C, Reimold M.

Clin Nucl Med. 2017 Sep;42(9):717-718. doi: 10.1097/RLU.0000000000001767.

PMID:
28777194
10.

SUV-quantification of physiological lung tissue in an integrated PET/MR-system: Impact of lung density and bone tissue.

Seith F, Schmidt H, Gatidis S, Bezrukov I, Schraml C, Pfannenberg C, la Fougère C, Nikolaou K, Schwenzer N.

PLoS One. 2017 May 31;12(5):e0177856. doi: 10.1371/journal.pone.0177856. eCollection 2017.

11.

Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial.

Welz S, Mönnich D, Pfannenberg C, Nikolaou K, Reimold M, La Fougère C, Reischl G, Mauz PS, Paulsen F, Alber M, Belka C, Zips D, Thorwarth D.

Radiother Oncol. 2017 Sep;124(3):526-532. doi: 10.1016/j.radonc.2017.04.004. Epub 2017 Apr 20.

PMID:
28434798
12.

Comparison of DCE-MRI kinetic parameters and FMISO-PET uptake parameters in head and neck cancer patients.

Simoncic U, Leibfarth S, Welz S, Schwenzer N, Schmidt H, Reischl G, Pfannenberg C, Fougère C, Nikolaou K, Zips D, Thorwarth D.

Med Phys. 2017 Jun;44(6):2358-2368. doi: 10.1002/mp.12228. Epub 2017 Apr 20.

13.

Impact of 18F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysis.

Forschner A, Olthof SC, Gückel B, Martus P, Vach W, la Fougère C, Nikolaou K, Keim U, Eigentler TK, Garbe C, Pfannenberg C.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1312-1318. doi: 10.1007/s00259-017-3674-8. Epub 2017 Mar 18.

PMID:
28315947
14.

Imaging of gastrointestinal melanoma metastases: Correlation with surgery and histopathology of resected specimen.

Othman AE, Eigentler TK, Bier G, Pfannenberg C, Bösmüller H, Thiel C, Garbe C, Nikolaou K, Klumpp B.

Eur Radiol. 2017 Jun;27(6):2538-2545. doi: 10.1007/s00330-016-4625-7. Epub 2016 Oct 17.

PMID:
27752834
15.

Managing Incidental Lung Nodules in Patients With a History of Oncologic Disease: A Survey of Thoracic Radiologists.

Occhipinti M, Heidinger BH, Pfannenberg C, Munden RF, Eisenberg RL, Bankier AA.

J Thorac Imaging. 2017 Mar;32(2):115-120. doi: 10.1097/RTI.0000000000000231.

PMID:
27643445
16.

Diagnosing Lung Nodules on Oncologic MR/PET Imaging: Comparison of Fast T1-Weighted Sequences and Influence of Image Acquisition in Inspiration and Expiration Breath-Hold.

Schwenzer NF, Seith F, Gatidis S, Brendle C, Schmidt H, Pfannenberg CA, laFougère C, Nikolaou K, Schraml C.

Korean J Radiol. 2016 Sep-Oct;17(5):684-94. doi: 10.3348/kjr.2016.17.5.684. Epub 2016 Aug 23.

17.

Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT.

Schwenck J, Rempp H, Reischl G, Kruck S, Stenzl A, Nikolaou K, Pfannenberg C, la Fougère C.

Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):92-101. Epub 2016 Aug 24.

PMID:
27557844
18.

Improving CT-Based PET Attenuation Correction in the Vicinity of Metal Implants by an Iterative Metal Artifact Reduction Algorithm of CT Data and Its Comparison to Dual-Energy-Based Strategies: A Phantom Study.

Schabel C, Gatidis S, Bongers M, Hüttig F, Bier G, Kupferschlaeger J, Bamberg F, la Fougère C, Nikolaou K, Pfannenberg C.

Invest Radiol. 2017 Jan;52(1):61-65.

PMID:
27416330
19.

CT imaging of bone and bone marrow infiltration in malignant melanoma--Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT.

Bier G, Hoffmann V, Kloth C, Othman AE, Eigentler T, Garbe C, La Fougère C, Pfannenberg C, Nikolaou K, Klumpp B.

Eur J Radiol. 2016 Apr;85(4):732-8. doi: 10.1016/j.ejrad.2016.01.012. Epub 2016 Jan 19.

PMID:
26971416
20.

Is It Possible to Detect Activated Brown Adipose Tissue in Humans Using Single-Time-Point Infrared Thermography under Thermoneutral Conditions? Impact of BMI and Subcutaneous Adipose Tissue Thickness.

Gatidis S, Schmidt H, Pfannenberg CA, Nikolaou K, Schick F, Schwenzer NF.

PLoS One. 2016 Mar 11;11(3):e0151152. doi: 10.1371/journal.pone.0151152. eCollection 2016.

21.

Robustness of quantitative hypoxia PET image analysis for predicting local tumor control.

Mönnich D, Welz S, Thorwarth D, Pfannenberg C, Reischl G, Mauz PS, Nikolaou K, la Fougère C, Zips D.

Acta Oncol. 2015;54(9):1364-9. doi: 10.3109/0284186X.2015.1071496.

PMID:
26481464
22.

Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma.

Schüle SC, Eigentler TK, Garbe C, la Fougère C, Nikolaou K, Pfannenberg C.

Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):482-8. doi: 10.1007/s00259-015-3187-2. Epub 2015 Sep 18.

PMID:
26384681
23.

Comparison of Positron Emission Tomography Quantification Using Magnetic Resonance- and Computed Tomography-Based Attenuation Correction in Physiological Tissues and Lesions: A Whole-Body Positron Emission Tomography/Magnetic Resonance Study in 66 Patients.

Seith F, Gatidis S, Schmidt H, Bezrukov I, la Fougère C, Nikolaou K, Pfannenberg C, Schwenzer N.

Invest Radiol. 2016 Jan;51(1):66-71. doi: 10.1097/RLI.0000000000000208.

PMID:
26348596
24.
25.

Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series.

Brendle C, Schwenzer NF, Rempp H, Schmidt H, Pfannenberg C, la Fougère C, Nikolaou K, Schraml C.

Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):123-32. doi: 10.1007/s00259-015-3137-z. Epub 2015 Jul 31.

PMID:
26224536
26.

[Multiple enlarged metabolically active lymph nodes in 18F-FDG PET/CT after anti-CTLA-4 antibody therapy in metastatic melanoma - disease progression or immunologically induced side effect?].

Schüle SC, Eigentler T, Pfannenberg C.

Rofo. 2015 Nov;187(11):1036-7. doi: 10.1055/s-0034-1399672. Epub 2015 Jun 10. German. No abstract available.

PMID:
26062178
27.

Patient comfort during positron emission tomography/magnetic resonance and positron emission tomography/computed tomography examinations: subjective assessments with visual analog scales.

Gückel B, Gatidis S, Enck P, Schäfer J, Bisdas S, Pfannenberg C, Schwenzer N.

Invest Radiol. 2015 Oct;50(10):726-32. doi: 10.1097/RLI.0000000000000177.

PMID:
26039772
28.

[Erratum to: Relapsing polychondritis. Primary and follow-up diagnostics with (18)F-FDG-PET/CT].

Schüle SC, Xenitidis T, Henes J, la Fougère C, Nikolaou K, Pfannenberg C.

Z Rheumatol. 2015 Apr;74(3):198. doi: 10.1007/s00393-015-1593-2. German. No abstract available.

PMID:
25854153
29.

[Relapsing polychondritis. Primary and follow-up diagnostics with (18)F-FDG-PET/CT].

Schüle SC, Xenitidis T, Henes J, la Fougère C, Nikolaou K, Pfannenberg C.

Z Rheumatol. 2015 Apr;74(3):246-9. doi: 10.1007/s00393-014-1560-3. German. Erratum in: Z Rheumatol. 2015 Apr;74(3):198.

PMID:
25644068
30.

[Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].

Pfannenberg C, Schwenzer N.

Radiologe. 2015 Feb;55(2):120-6. doi: 10.1007/s00117-014-2762-z. German.

PMID:
25589421
31.

Segmentation-based attenuation correction in positron emission tomography/magnetic resonance: erroneous tissue identification and its impact on positron emission tomography interpretation.

Brendle C, Schmidt H, Oergel A, Bezrukov I, Mueller M, Schraml C, Pfannenberg C, la Fougère C, Nikolaou K, Schwenzer N.

Invest Radiol. 2015 May;50(5):339-46. doi: 10.1097/RLI.0000000000000131.

PMID:
25585210
32.

Image-derived biomarkers and multimodal imaging strategies for lung cancer management.

Sauter AW, Schwenzer N, Divine MR, Pichler BJ, Pfannenberg C.

Eur J Nucl Med Mol Imaging. 2015 Apr;42(4):634-43. doi: 10.1007/s00259-014-2974-5. Epub 2015 Jan 9. Review.

PMID:
25573632
33.

Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methods.

Brendle C, Kupferschläger J, Nikolaou K, la Fougère C, Gatidis S, Pfannenberg C.

Eur J Radiol. 2015 Jan;84(1):158-162. doi: 10.1016/j.ejrad.2014.10.018. Epub 2014 Nov 1.

PMID:
25467224
34.

11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.

Braeuning U, Pfannenberg C, Gallwitz B, Teichmann R, Mueller M, Dittmann H, Reimold M, Bares R.

Nuklearmedizin. 2015;54(1):26-30. doi: 10.3413/Nukmed-0686-14-07. Epub 2014 Nov 27.

PMID:
25427653
35.

Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results.

Schäfer JF, Gatidis S, Schmidt H, Gückel B, Bezrukov I, Pfannenberg CA, Reimold M, Ebinger M, Fuchs J, Claussen CD, Schwenzer NF.

Radiology. 2014 Oct;273(1):220-31. doi: 10.1148/radiol.14131732. Epub 2014 May 31.

PMID:
24877983
36.

Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.

Klumpp B, Schwenzer NF, Gatidis S, Koenigsrainer I, Koenigsrainer A, Beckert S, Mueller M, Claussen CD, Pfannenberg C.

Rofo. 2014 Apr;186(4):359-66. doi: 10.1055/s-0034-1366041. Epub 2014 Mar 28.

37.

Implications of glycoprotein VI for theranostics.

Gawaz M, Vogel S, Pfannenberg C, Pichler B, Langer H, Bigalke B.

Thromb Haemost. 2014 Jul 3;112(1):26-31. doi: 10.1160/TH13-09-0756. Epub 2014 Feb 20. Review.

PMID:
24553806
38.

Correlation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results.

Klumpp B, Aschoff P, Schwenzer N, Koenigsrainer I, Beckert S, Claussen CD, Miller S, Koenigsrainer A, Pfannenberg C.

Cancer Imaging. 2013 Dec 30;13(4):540-7. doi: 10.1102/1470-7330.2013.0044.

39.

Is there any additional benefit of contrast-enhanced CT as part of routine PET/CT protocols for the differentiation of suspicious incidental gastrointestinal 2-deoxy-(18)F-FDG uptake?

Brendle CB, Aschoff P, Kratt T, Schraml C, Reimold M, Claussen CD, Pfannenberg CA.

Korean J Radiol. 2013 Nov-Dec;14(6):951-9. doi: 10.3348/kjr.2013.14.6.951. Epub 2013 Nov 5.

40.

Peptide receptor radionuclide therapy of neuroendocrine tumors with (90)Y-DOTATOC: is treatment response predictable by pre-therapeutic uptake of (68)Ga-DOTATOC?

Öksüz MÖ, Winter L, Pfannenberg C, Reischl G, Müssig K, Bares R, Dittmann H.

Diagn Interv Imaging. 2014 Mar;95(3):289-300. doi: 10.1016/j.diii.2013.07.006. Epub 2013 Sep 12.

41.

Simultaneously acquired MR/PET images compared with sequential MR/PET and PET/CT: alignment quality.

Brendle CB, Schmidt H, Fleischer S, Braeuning UH, Pfannenberg CA, Schwenzer NF.

Radiology. 2013 Jul;268(1):190-9. doi: 10.1148/radiol.13121838. Epub 2013 May 8.

PMID:
23657890
42.

Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.

Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.

Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1.

PMID:
23519008
43.

Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.

Schraml C, Schwenzer NF, Sperling O, Aschoff P, Lichy MP, Müller M, Brendle C, Werner MK, Claussen CD, Pfannenberg C.

Cancer Imaging. 2013 Mar 5;13:63-72. doi: 10.1102/1470-7330.2013.0007.

44.

Imaging findings and therapy response monitoring in chronic sclerodermatous graft-versus-host disease: preliminary data of a simultaneous PET/MRI approach.

Sauter AW, Schmidt H, Mantlik F, Kolb A, Federmann B, Pfannenberg C, Reimold M, Pichler BJ, Bethge W, Horger MS.

Clin Nucl Med. 2013 Aug;38(8):e309-17. doi: 10.1097/RLU.0b013e3182816559.

PMID:
23455525
45.

Correlation between [¹⁸F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer.

Sauter AW, Spira D, Schulze M, Pfannenberg C, Hetzel J, Reimold M, Klotz E, Claussen CD, Horger MS.

Eur J Nucl Med Mol Imaging. 2013 May;40(5):677-84. doi: 10.1007/s00259-012-2318-2. Epub 2013 Jan 10.

PMID:
23306806
46.

Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.

Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U.

Invest Radiol. 2013 May;48(5):295-301. doi: 10.1097/RLI.0b013e31827188d6.

PMID:
23296081
47.

Simultaneous PET/MR imaging of the brain: feasibility of cerebral blood flow measurements with FAIR-TrueFISP arterial spin labeling MRI.

Stegger L, Martirosian P, Schwenzer N, Bisdas S, Kolb A, Pfannenberg C, Claussen CD, Pichler B, Schick F, Boss A.

Acta Radiol. 2012 Nov 1;53(9):1066-72. doi: 10.1258/ar.2012.120191.

PMID:
23117845
48.

Combined PET/MR imaging using (68)Ga-DOTATOC for radiotherapy treatment planning in meningioma patients.

Thorwarth D, Müller AC, Pfannenberg C, Beyer T.

Recent Results Cancer Res. 2013;194:425-39. doi: 10.1007/978-3-642-27994-2_23.

PMID:
22918773
49.

[Application of MR/PET in oncologic imaging].

Schwenzer NF, Pfannenberg C, Reischl G, Werner MK, Schmidt H.

Rofo. 2012 Sep;184(9):780-7. doi: 10.1055/s-0031-1299334. Epub 2012 May 22. Review. German.

PMID:
22618473
50.

Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI.

Klumpp BD, Schwenzer N, Aschoff P, Miller S, Kramer U, Claussen CD, Bruecher B, Koenigsrainer A, Pfannenberg C.

Abdom Imaging. 2013 Feb;38(1):64-71. doi: 10.1007/s00261-012-9881-7.

PMID:
22476333

Supplemental Content

Loading ...
Support Center